Strategies for the assessment of genetic coronary artery disease risk

Current Opinion in Lipidology

Volumn 10, Issue 3, 1999, Pages 285-291

  Funke, Harald ^a,b   Assmann, Gerd ^a  

^a Inst of Arteriolsclerosis Research   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; MEDICAL DECISION MAKING; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

CORONARY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS;

EID: 0032864475     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199906000-00011     Document Type: Review

References (67)

1. 1 Assmann G, Schulte H, Cullen P. New and classical risk factors-the Munster heart study (PROCAM). Eur J Med Res 1997; 2:237-242.
2. 2 Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med 1981; 141:1128-1131.
3. 3 Frick MH, Elo O, Haapa K, Heinonen OP, Heisalmi P, Helo P, et al. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317:1237-1245.
4. 4 Assmann G, Schulte H, Cullen P. New and classical risk factors-the Munster heart study (PROCAM). Eur J Med Res 1997; 2:237-242.
5. 5 Wilson PW, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study) [published erratum appears in Am J Cardiol 1987 1;60A11]. Am J Cardiol 1987; 59:91G-94G.
6. 6 Botstein D, White RL, Skolnick M, Davis RW. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 1980; 32:314-331.
7. 7 Funke H, Von Eckardstein A, Assmanan G. Molecular genetics approach to polygenic disease results from atherosclerosis research. In: Galton DJ, Assman G (eds.) DNA Polymorphisms as Disease Markers. Plenum Press New York, 15-25 1991.
8. 8 Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 1988; 42:113-124.
9. 9 Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8:1-21.
10. 10 Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol and coronary artery disease. Clin Chem 1986; 32:778-781.
11. 11 Dammerman M, Sandkuhl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci (USA) 1993; 90:4562-4566.
12. 12 Dallinga-Thie GM, Van Linde-Sibenius TM, Rotter JI, Cantor RM, X, Lusis AJ, De BT. Complex genetic contribution of the apoptosis AI-CIII-AIV gene cluster to familial combined hyperlipidemia: identification of different susceptibility haplotypes. J Clin Invest 1997; 99:953-961.
13. 13 Antonarakis SE, Oettgen P, Chakravarti A, Halloran SL, Hudson RR, Feisee L, Karathanasis SK. DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum Genet 1988; 80:265-273.
14. 14 Lehrmann MA, Schneider WJ, S-Dhoff TC, Brown MS, Goldstein JL, Russell DW. Mutation in LDL receptor: alu-alu recombination deletex onons encoding transmembrane and cytoplasmic domains. Science 1985; 227:140-146.
15. 15 Karathanasis SK, Zannis VI, Breslow JL. A DNA insertion in the apolipoprotein AI gene of patients with premature atherosclerosis. Nature 1983; 305:823-825.
16. 16 Taramelli R, Pontoglio M, Candiani G, Ottolenghi S, Dieplinger H, Catapano A, Albers J, et al. Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele. Hum Genet 1990; 85:195-199.
17. 17 Funke H, Von EA, Pritchard PH, Albers JJ, Kastelein JJ, Droste C, Assmann G. A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci USA 1991; 88:4855-4859.
18. 18 Brown ML, Inazu A, Hester CB, Agellon LB, Mann C, Whitlock ME, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989; 342:448-451.
19. 19 Funke H. Genetic determinants of high density lipoprotein levels. Curr Opin Lipidol 1997; 8:189-196.
20. 20 Wetterau JR, Aggerbeck LP, Bourma ME, Eisenberg C, Munck A, Hermier M, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992; 258:999-1001.
21. 21 Knott TJ, Wallis SC, Powell LM, Pease RJ, Lusis AJ, Blackhart B, et al. Complete cDNA and derived protein sequence of human apolipoprotein B-100. Nucleic Acids Res 1986; 14:7501-7503.
22. 22 Mclean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132-137.
23. 23 Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 1988; 7:4119-4127.
24. 24 Scott J, Wallis SC, Davies MS, Wynne JK, Powell LM, Driscoll DM. RNA editing: a novel mechanism for regulating lipid transport from the intestine. Gut 1989; 30 Spec No:35-43.
25. 25 Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991; 353:265-267.
26. 26 Williamson R, Lee D, Hagaman J, Maeda N. Marked reduction of high density lipoprotein cholesterol in mice geneticaly modified to lack apolipoprotein A-I. Proc Natl Acad Sci USA 1992; 89: 7134-7138.
27. 27 Li H, Reddick RL, Maeda N. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler Thromb 1993; 13:1814-1821.
28. 28 Berard AM, Foger B, Remaley A, Shamburek R, Vaisman BL, Talley G, et al. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat Med 1997; 3:744-749.
29. 29 Hoeg JM, Santamarina-Fojo S, Berard AM, Cornhill JF, Herderick EE, Feldman SH, et al. Overexpression of lecithin: cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci USA 1996; 93:11448-11453.
30. 30 Castellani LW, Weinreb A, Bodnar J, Goto AM, Doolittle M, Mehrabian M, et al. Mapping a gene for combined hyperlipdiaemia in a mutant mouse strain. Nat Genet 1998; 18:374-377.
31. 31 Pajukanta P, Nuotio I, Terwilliger JD, Porkka KV, Ylitalo K, Pihlajamaki J, et al. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet 1998; 18:369-373.
32. 32 Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, et al. Identification of CD36 (fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats [in process citation]. Nat Genet 1999; 21;76-83.
33. 33 Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997; 15:273-276.
34. 34 Jackson SN, Pinkney J, Bargiotta A, Veal CD, Howlett TA, Mcnally PG, et al. A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q. Am J Hum Genet 1998; 63:534-540.
35. 35 Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet 1998; 18:292-295.
36. 36 Anderson JL, Khan M, David WS, Mahdavi Z, Nuttall FQ, Krech E, et al. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22 [in process citation]. Am J Med Genet 1999; 82:161-165.
37. 37 Kruglyak L, Lander ES. A nonparametric approach for mapping quantitative trait loci. Genetics 1995; 139:1421-1428.
38. 38 Mccarthy MI, Kruglyak L, Lander ES. Sib-pair collection strategies for complex diseases. Genet Epidemiol 1998; 15:317-340.
39. 39 Risch N. Linkage strategies for genetically complex traits. i. Multilocus models [see comments]. Am J Hum Genet 1990; 46:222-228.
40. 40 Risch N. Linkage strategies for genetically complex traits. ii. The power of affected relative pairs [see comments]. Am J Hum Genet 1990; 46:229-241.
41. 41 Risch N. Linkage strategies for genetically complex traits. iii. The effect of marker polymorphism on analysis of affected relative pairs [published erratum appears in Am J Hum Genet 1992 Sep;51 (3:673-5] [see comments]. Am J Hum Genet 1990; 46:242-253.
42. 42 Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995; 268:1584-1589.
43. 43 Risch N, Merikangas K. The future of genetic studies of complex human diseases [see comments]. Science 1996; 273:1516-1517.
44. 44 Valle T, Tuomilehto J, Bergman RN, Ghosh S, Hauser ER, Eriksson J, et al. Mapping genes for NIDDM. Design of the Finland-United States investigation of NIDDM genetics (FUSION) study. Diabetes Care 1998; 21:949-958.
45. 45 Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58:1347-1363.
46. 46 Mahtani MM, Widen E, Lehto M, Thomas J, Mccarthy M, Brayer J, et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish familes [see comments]. Nat Genet 1996; 14:90-94.
47. 47 Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet 1998; 20:304-308.
48. 48 Wojciechowski AP, Farrall ML, Cullen P, Wilson TME, Bayliss JD, Farren B, et al. Familial combined hyperlipidemia is linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-Q24. Nature 1991; 349:161-164.
49. 49 Rust S, Walter M, Funke H, Von EA, Cullen P, Kroes HY, et al. Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy [published erratum appears in Nat Genet 1998 Nov;20(3).312]. Nat Genet 1998; 20:96-98.
50. 50 Brown MS, Goldstein JL. The SREBP pathway; regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-340.
51. 51 Harnish DC, Malik S, Kilbourne E, Costa R, Karathanasis SK. Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. J Biol Chem 1996; 271:13621-13628.
52. 52 Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996; 10:1096-1107.
53. 53 Elbrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz M, Moller DE, Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 1996; 224:431-437.
54. 54 Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPAR-gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93:241-252.
55. 55 Saez E, Tontonoz P, Nelson MC, Alvarez JG, Ming UT, Baird SM, et al. Activators of the nuclear receptor PPAR-gamma enhance colon polyp formation. Nat Med 1998; 4:1058-1061.
56. 56 Harnish DC, Evans MJ, Scicchitano MS, Bhat RA, Karathanasis SK. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing. J Biol Chem 1998; 273:9270-9278.
57. 57 Duncan SA, Navas MA, Dufort D, Rossant J, Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science 1998; 281:692-695.
58. 58 Nakshatri H, Bhat-Nakshatri P. Multiple Parameters Determine The specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res 1998; 26:2491-2499.
59. 59 Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93:693-704.
60. 60 Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Huffman C, et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme a reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 1980; 77:3957-3961.
61. 61 Ma PT, Gil G, Sudhof TC, Bilheimer DW, Goldstein JL, Brown MS. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA 1986; 83:8370-8374.
62. 62 Cullen P, Assmann G. Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease. absolute levels or extent of lowering? Am J Cardiol 1997; 80:1287-1294.
63. 63 Day IN, Humphries SE, Richards S, Norton D, Reid M. High-throughput genotyping using horizontal polyacrylamide gels with wells arranged for microplate array diagonal gel electrophoresis (MADGE). Biotechniques 1995; 19:830-835.
64. 64 Cheng S, Pallaud C, Grow MA, Scharf SJ, Erlich HA, Kitz W, et al. A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 1998; 36:561-566.
65. 65 Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1:445-446
66. 66 Muntoni S, Wiebusch H, Funke H, Ros E, Seedorf U, Assmann G. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase. In: A Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet 1995; 95:491-49.
67. 67 Tall AR. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J Intern Med 1995; 237:5-12.